Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.

Esophageal adenocarcinoma (EAC) is thought to develop through a multistage process in which Barrett's metaplasia progresses through low- and high-grade dysplasia to invasive cancer. Transcriptional silencing of tumor suppressor genes by promoter CpG island hypermethylation has been observed in many types of human cancer. Analysis of CpG island hypermethylation in EAC has thus far been limited to the CDKN2A (p16) gene. In this study, we extend the methylation analysis of EAC to include three other genes, APC, CDH1 (E-cadherin), and ESR1 (ER, estrogen receptor alpha), in addition to CDKN2A. Molecular analysis can provide insight into the complex relationships between tissues with different histologies in Barrett's esophagus and associated adenocarcinoma. Therefore, we have mapped the spatial distribution of methylation patterns in six esophagectomy cases in detail. Hypermethylation of the four CpG islands was analyzed by the MethyLight technique in 107 biopsies derived from these six patients for a total of 428 methylation analyses. Our results show that normal esophageal squamous epithelium is unmethylated at all four CpG islands. CDH1 is unmethylated in most other tissue types as well. Hypermethylation of ESR1 is seen at high frequency in inflammatory reflux esophagitis and at all subsequent stages, whereas APC and CDKN2A hypermethylation is found in Barrett's metaplasia, dysplasia, and EAC. When it occurs, hypermethylation of APC, CDKN2A, and ESR1 is usually found in a large contiguous field, suggesting either a concerted methylation change associated with metaplasia or a clonal expansion of cells with abnormal hypermethylation.

[1]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[2]  M. Toyota,et al.  Distinct methylation pattern and microsatellite instability in sporadic gastric cancer , 1999, International journal of cancer.

[3]  Carissa A. Sanchez,et al.  p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.

[4]  W. Dinjens,et al.  E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus , 1999, British Journal of Cancer.

[5]  P. Laird,et al.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.

[6]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[7]  D. Kerr,et al.  Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. , 1999, The American journal of pathology.

[8]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[9]  C. Hsieh,et al.  Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. , 1998, Gastroenterology.

[10]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[11]  K. Washington,et al.  Expression of β-catenin, α-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas , 1998 .

[12]  P. Jones,et al.  The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. , 1998, Cancer research.

[13]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[14]  J. Peters,et al.  Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. , 1997, Annals of surgery.

[15]  D. Wong,et al.  p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. , 1997, Cancer research.

[16]  P. Laird.  Oncogenic mechanisms mediated by DNA methylation. , 1997, Molecular medicine today.

[17]  V. Kosma,et al.  Hypermethylation of the APC (adenomatous Polyposis Coli) gene promoter region in human colorectal carcinoma , 1997, International journal of cancer.

[18]  V. Álvarez,et al.  Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma. , 1997, Journal of clinical pathology.

[19]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[20]  Carissa A. Sanchez,et al.  Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. , 1996, Oncogene.

[21]  L. Liotta,et al.  Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. , 1996, Cancer research.

[22]  G. Triadafilopoulos,et al.  E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. , 1995, The American journal of gastroenterology.

[23]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[24]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[25]  R. Whyte,et al.  E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus. , 1995, British Journal of Cancer.

[26]  K. Kinzler,et al.  APC gene mutations in the mutation cluster region are rare in esophageal cancers. , 1994, Gastroenterology.

[27]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[28]  T. McDaniel,et al.  Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. , 1993, Cancer research.

[29]  Patricia L. Blount,et al.  Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. , 1992, Cancer research.

[30]  D. Cox,et al.  Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. , 1992, American journal of human genetics.

[31]  Patricia L. Blount,et al.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.